Mahmoud E Nazzal, Mohammed A Saadah, Loai M Saadah, Mahmoud A Al-Omari, Ziad A Al-Oudat, Mohammed S Nazzal, Mahfoud Y El-Beshari, Amani A Al-Zaabi, Yousif I Alnuaimi
{"title":"Management options of chronic low back pain. A randomized blinded clinical trial.","authors":"Mahmoud E Nazzal, Mohammed A Saadah, Loai M Saadah, Mahmoud A Al-Omari, Ziad A Al-Oudat, Mohammed S Nazzal, Mahfoud Y El-Beshari, Amani A Al-Zaabi, Yousif I Alnuaimi","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To compare efficacies of 2 active programs in the management of chronic low back pain (CLBP).</p><p><strong>Methods: </strong>This prospective, stratified, randomized single-blinded controlled study was conducted in the Department of Rehabilitation Medicine, King Abdullah University Hospital, Irbid, Jordan, between February and December 2010. A total of 100 patients were randomized to either 6-weeks of multidisciplinary rehabilitation (group A) or therapist-assisted exercise (group B). At baseline and 6 weeks, the visual analogue scale (VAS) pain score was estimated, as a primary outcome measure. McGill pain score, Oswestry Disability Index (ODI), trunk forward flexion and extension, left and right lateral bending, were applied before and after treatment and were employed as secondary outcome measures.</p><p><strong>Results: </strong>All outcome measures significantly improved in group A after treatment, compared with group B. The VAS, McGill, ODI scores, left and right lateral bending decreased significantly, whereas forward and backward bending increased. A significant number of patients returned to work in group A at the end of 6 weeks, compared with group B. These effects were maintained over 12 and 24 weeks of follow-up.</p><p><strong>Conclusion: </strong>Multidisciplinary rehabilitation improved functional indices and pain scale scores in group A compared with B. This would be an effective strategy in CLBP management.</p>","PeriodicalId":520723,"journal":{"name":"Neurosciences (Riyadh, Saudi Arabia)","volume":" ","pages":"152-9"},"PeriodicalIF":0.9,"publicationDate":"2013-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40240556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Protective effect of coenzyme Q10 in paclitaxel-induced peripheral neuropathy in rats.","authors":"Nalan Celebi, Hemra Cil, Onur Cil, Ozgur Canbay, Rustu Onur, Ulku Aypar","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the possible protective effect of coenzyme Q10 (CQ10) on neuropathy in rats.</p><p><strong>Methods: </strong>Experiments were conducted in the Department of Pharmacology, Faculty of Medicine, Hacettepe University, Ankara, Turkey between January and March 2012. Forty rats were divided into 4 groups: group 1 (control), group 2 (paclitaxel), group 3 (control + CQ10), and group 4 (paclitaxel + CQ10). Group 2 and 4 rats received paclitaxel (2 mg/kg, intraperitoneally, on days 0, 2, 4, 6). Group 3 and 4 rats were treated with CQ10 (10 mg/kg, intraperitoneally, on days 0, 1, 2, 3, 4, 5, 6, 7, 8, 9). The rats that did not receive paclitaxel or CQ10 received vehicle. Mechanical allodynia tests were performed for each animal on day 0, 2, 6, 8, 10, 14, 16, 19, 39 and 41 for all groups with von Frey filaments.</p><p><strong>Results: </strong>At day 0, mean mechanical withdrawal thresholds were similar among all groups. Starting from day 2, the threshold of the paclitaxel group decreased. Starting from day 10, paclitaxel+CQ10 treated rats had significantly higher thresholds compared with the paclitaxel group, but these values were still significantly lower than that of the controls. Control and control + CQ10 rats had similar threshold values during the protocol.</p><p><strong>Conclusion: </strong>The CQ10 treatment decreased the degree of paclitaxel-induced peripheral neuropathy in rats.</p>","PeriodicalId":520723,"journal":{"name":"Neurosciences (Riyadh, Saudi Arabia)","volume":" ","pages":"133-7"},"PeriodicalIF":0.9,"publicationDate":"2013-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40240552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Heidar N Farahani, Alireza R Ashthiani, Mher S Masihi
{"title":"Study on serum zinc and selenium levels in epileptic patients.","authors":"Heidar N Farahani, Alireza R Ashthiani, Mher S Masihi","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To estimate serum zinc and selenium levels in a group of healthy subjects and correlate these with epileptic patients.</p><p><strong>Methods: </strong>This case-control study was conducted in the Department of Neurology, Valiasr Hospital, Iran, between November 2011 and May 2012 on 40 patients aged 26.63+/-5.78 years who were diagnosed with generalized and a single epileptic form of epilepsy by a neurologist for the first time. The control group was selected from healthy individuals, and matched to the case group. Serum zinc was measured by the calorimetric method using a Randox kit. Selenium was measured by atomic absorption spectroscopy.</p><p><strong>Results: </strong>The mean zinc level was 151.2+/-29.75 ug/dl in the cases, and 181.63+/-60.19 ug/dl in the controls (p=0.006). The mean selenium level was 73.37+/-13.31 ug/l in cases compared with 85.55+/-19.39 ug/dl in controls (p=0.002). We also found a significant difference between the selenium levels by gender in the 2 groups (p=0.03).</p><p><strong>Conclusion: </strong>We observed statistically significant changes in serum zinc and selenium levels of epileptic adult patients in comparison with the control group. As zinc and selenium are used as potent antioxidants in cellular interactions, changes in their serum values may result in enzymatic changes, which in turn can cause neurological disorders.</p>","PeriodicalId":520723,"journal":{"name":"Neurosciences (Riyadh, Saudi Arabia)","volume":" ","pages":"138-42"},"PeriodicalIF":0.9,"publicationDate":"2013-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40240553","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Amro F Al-Habib, Saad M Al-Rashidi, Fahad B Al-Badr, Hamdy H Hassan
{"title":"Radiological predictors of neurological compromise in adults with filum terminale lipoma.","authors":"Amro F Al-Habib, Saad M Al-Rashidi, Fahad B Al-Badr, Hamdy H Hassan","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":520723,"journal":{"name":"Neurosciences (Riyadh, Saudi Arabia)","volume":" ","pages":"180-2"},"PeriodicalIF":0.9,"publicationDate":"2013-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40240459","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Platelet alloantigen polymorphism and migraine headaches.","authors":"Shalini Bhaskar, Jafri M Abdullah","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":520723,"journal":{"name":"Neurosciences (Riyadh, Saudi Arabia)","volume":" ","pages":"185-6"},"PeriodicalIF":0.9,"publicationDate":"2013-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40240461","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Hypertensive encephalopathy as the initial manifestation of Guillain-Barré syndrome in a 7-year-old girl.","authors":"Ayman A Aleyadhy, Gamal M Hassan","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>We report a case involving a 7-year-old girl who initially presented with seizure and hypertensive encephalopathy, serious autonomic manifestations associated with Guillain-Barré syndrome, followed by subsequent bilateral ascending flaccid paralysis. Cerebrospinal fluid analysis showed cytoalbuminous dissociation. Nerve conduction velocity tests showed features of demyelinating polyradiculoneuropathy. An immunofluorescence test of her serum was positive for mycoplasma immunoglobulin M antibody. The present case highlights the importance of considering the initial autonomic manifestations of Guillain-Barré syndrome in the differential diagnosis of unexplained acute hypertensive crisis.</p>","PeriodicalId":520723,"journal":{"name":"Neurosciences (Riyadh, Saudi Arabia)","volume":" ","pages":"163-5"},"PeriodicalIF":0.9,"publicationDate":"2013-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40240453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Co-morbid Guillain-Barré syndrome and acute disseminated encephalomyelitis.","authors":"Reema R Mohammed, Mohammed M Jan","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Guillain-Barré syndrome (GBS) and acute disseminated encephalomyelitis (ADEM) are clinically distinct demyelinating disorders that share an autoimmune pathogenesis and prior history of viral infection or vaccination. Concurrent GBS and ADEM are uncommon with few reported cases. Our patient is a 10-year-old girl who presented with acute quadriparesis, areflexia, and urinary retention. Lumber puncture revealed mild pleocytosis and elevated protein. She required mechanical ventilation and failed to improve after intravenous immunoglobulins. She subsequently developed double vision and disturbed level of consciousness. Brain MRI revealed multiple white matter lesions suggestive of ADEM. Based on the temporal association and exclusion of alternative etiologies, we made a diagnosis of GBS and ADEM. She improved remarkably after intravenous methylprednisolone. We conclude that co-morbid GBS and ADEM is an uncommon entity presenting with severe neurological morbidity. Prompt recognition and treatment can hasten the recovery and therefore improve the neurological outcome.</p>","PeriodicalId":520723,"journal":{"name":"Neurosciences (Riyadh, Saudi Arabia)","volume":" ","pages":"166-8"},"PeriodicalIF":0.9,"publicationDate":"2013-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40240454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Aliasghar Pourshanazari, John Ciriello, Haleh Tajadini
{"title":"Role of 17-beta estradiol in baroreflex sensitivity in the nucleus tractus solitarii via the autonomic system in ovariectomized rats.","authors":"Aliasghar Pourshanazari, John Ciriello, Haleh Tajadini","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the effect of estrogen exerted through the autonomic system in the nucleus tractus solitarii (NTS) on increasing the sensitivity of the baroreflex under conditions of acute hypertension in ovariectomized rats.</p><p><strong>Methods: </strong>In this experimental study, conducted in Kerman University of Medical Sciences, Kerman, Iran from March 2010 to October 2010, 36 female rats were ovariectomized and then estrogen capsules were implanted beneath their skin. After 2 weeks, the left femoral vein and artery were cannulated for phenylephrine infusion and recording of mean arterial pressure and heart rate. Subsequently, atropine, propranolol, and saline were injected into the NTS, followed by measurements of changes in heart rate and changes in mean arterial pressure just prior to phenylephrine infusion.</p><p><strong>Results: </strong>Estrogen increased the bradycardia response and inhibited the rise of mean arterial pressure; namely, after phenylephrine infusion, the change in heart rate was significantly lower in the estrogen-receiving group compared with the control group (p<0.05). Baroreflex sensitivity was significantly increased in the estrogen-receiving group compared with the control group (p<0.01). Baroreflex sensitivity was significantly attenuated in both groups (estrogen-receiving and control) after atropine injection, compared with after propranolol or saline injection (p<0.01).</p><p><strong>Conclusion: </strong>It is probable that under conditions of acute hypertension, estrogen affects the NTS through the parasympathetic system and enhances baroreflex sensitivity.</p>","PeriodicalId":520723,"journal":{"name":"Neurosciences (Riyadh, Saudi Arabia)","volume":" ","pages":"126-32"},"PeriodicalIF":0.9,"publicationDate":"2013-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40240551","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Nancy N Maalouf, Archana Hinduja, Bashir S Shihabuddin
{"title":"Primary antiphospholipid syndrome manifesting as partial status epilepticus.","authors":"Nancy N Maalouf, Archana Hinduja, Bashir S Shihabuddin","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Primary antiphospholipid syndrome (APS) is an autoimmune disease defined by vascular thrombosis, pregnancy complications, and persistent antiphospholipid antibodies. Neurological manifestations include stroke, seizures, and chorea among others. Seizures are often precipitated by an acute ischemic event, but occasionally, structural abnormalities are absent. We present a 61-year-old man who developed partial seizures that progressed into partial status epilepticus. His seizures were intractable and required aggressive treatment with multiple anti-epileptic medications. He was diagnosed with primary APS and treated with anticoagulation. Head imaging did not reveal any acute ischemic events. This case demonstrates that primary APS may present as a refractory status epilepticus unrelated to acute cerebral ischemia.</p>","PeriodicalId":520723,"journal":{"name":"Neurosciences (Riyadh, Saudi Arabia)","volume":" ","pages":"160-2"},"PeriodicalIF":0.9,"publicationDate":"2013-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40240452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}